Did you know?
You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)
Re: Resverlogix Announces Publication on Apabetalone in Clinical Epigenetics
"Since half patients are placebo and half are apabetalone, yes one should be able to double the apabetalone patient year estimate to obtain the total trial patient year estimate. With my revisions above, this BETonMACE total patient years would be 4960 to 5432 total BETonMACE patient years." (I added bolding)
Would a power of .80 (80%) to the above numbers apply here?
